Mesenchymal lineage precursors or stem cells with enhanced immunosuppression

摘要

The present disclosure relates to cell therapy products comprising mesenchymal lineage precursors or stem cells and efficacy assays for these products. The present disclosure also provides methods for the treatment of immune or inflammatory disorders by administration of mesenchymal lineage precursors or stem cells, and for the treatment or prevention of graft versus host disease (GVHD), or one or more symptoms associated with GVHD. It is about.